Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Secondary CMV disease may occur in CMV- seropositive (R+) SOT recipients, either as reactivation (of endogenous latent CMV in the recipient) or super- infection (with CMV transmitted by transplantation) ( 23). Allostimulation, allograft rejection, and intense pharmacologic immunosuppression, particularly with antithymocyte-immunoglobulin therapy, combine to provide an environment that permits CMV reactivation after SOT ( 25)
If you want to change selection, open document below and click on "Move attachment"


owner: memeyrie - (no access) - CMV ASM.pdf, p3


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.